Type I Interferon in Chronic Virus Infection and Cancer.
about
Immune Evasion Strategies during Chronic Hepatitis B and C Virus InfectionMicroRNA 31 inhibits CD8(+) T-cell function by increasing its sensitivity to type I interferon signaling in chronic viral infection.Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism.Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity.LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer.Crucial role of miR-31 in induction of CD8+ T-cell exhaustion and reinforcement of type 1 interferon signaling.Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection.Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures.Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy.Immune regulation of the unfolded protein response at the mucosal barrier in viral infection.miRNA-31 regulates the CD8 T cell response to type I IFNs during chronic infection.The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer.Stretching Reduces Tumor Growth in a Mouse Breast Cancer Model.Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to ResistanceEnhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10
P2860
Q39327457-DD2C3528-9262-4602-B46C-A7458FCEB115Q41926840-DA13C6A5-8E20-47D4-87CC-80DF20DB69D5Q42378527-2E5AE352-A431-4ECB-A3CE-12FD2B6BF059Q47221276-A13CB72D-6748-44AE-BB18-76BA761E2F90Q47558114-3533F5B8-EED9-4766-9B65-99A2CED46C17Q48208504-0FFEF129-6488-479F-9102-831A1AE4E08AQ49615049-DBFD4A69-5837-47BE-8932-B2AE64359A6AQ49829392-D2B7C743-8FAD-40CF-9174-4F3D483E39E6Q52348476-09497246-9CC7-4F03-8AB0-4862F502097FQ52606149-7560FEFD-1340-44F3-82F1-A47E77EBB03AQ54238990-056177E8-10D6-49E7-B907-CC5D2FF896F2Q54257075-5B852EAE-91A1-41B8-9048-A03EDCA68F96Q55078034-758E1AB4-0188-4BBF-A8DD-3944E778B6AFQ55215695-85FAC565-FB96-4FDB-9066-C3033A4BB5CEQ55352762-39E0F2AB-EDF4-4168-A245-7BD98D56357BQ58729482-E7EF3D09-03EC-4EF9-BF9D-5BF901D8EF08Q58767527-BAB48FE9-88DE-4EFD-92B0-247C5A141541
P2860
Type I Interferon in Chronic Virus Infection and Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Type I Interferon in Chronic Virus Infection and Cancer.
@en
Type I Interferon in Chronic Virus Infection and Cancer.
@nl
type
label
Type I Interferon in Chronic Virus Infection and Cancer.
@en
Type I Interferon in Chronic Virus Infection and Cancer.
@nl
prefLabel
Type I Interferon in Chronic Virus Infection and Cancer.
@en
Type I Interferon in Chronic Virus Infection and Cancer.
@nl
P356
P1433
P1476
Type I Interferon in Chronic Virus Infection and Cancer
@en
P2093
David G Brooks
Laura M Snell
P304
P356
10.1016/J.IT.2017.05.005
P577
2017-05-31T00:00:00Z